EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Insights into the Dietary Role of Glucoraphanin and Its Metabolite Sulforaphane in Celiac Disease

Elisa Sonzogni iD, Giulia Martinelli iD, Marco Fumagalli, Nicole Maranta iD, Carola Pozzoli iD, Corinne Bani iD, Luigi Alberto Marrari, Chiara Di Lorenzo iD, Enrico Sangiovanni iD, Mario Dell'Agli iD, Stefano Piazza iD

Nutrients · 2024

DOI: 10.3390/nu16162743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Elisa Sonzogni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti" (DiSFeB), Università Degli Studi di Milano, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Isothiocyanates, Sulfoxides, Glucosinolates, Celiac Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIUR, Naturalsalus s.r.l. (MI) Italy, MIUR “Progetto Eccellenza” 2023–2027.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulforaphane is considered the bioactive metabolite of glucoraphanin after dietary consumption of broccoli sprouts. Although both molecules pass through the gut lumen to the large intestine in stable form, their biological impact on the first intestinal tract is poorly described. In celiac patients, the function of the small intestine is affected by celiac disease (CD), whose severe outcomes are controlled by gluten-free dietary protocols. Nevertheless, pathological signs of inflammation and oxidative stress may persist. The aim of this study was to compare the biological activity of sulforaphane with its precursor glucoraphanin in a cellular model of gliadin-induced inflammation. Human intestinal epithelial cells (CaCo-2) were stimulated with a pro-inflammatory combination of cytokines (IFN-γ, IL-1β) and in-vitro-digested gliadin, while oxidative stress was induced by H2O2. LC-MS/MS analysis confirmed that sulforaphane from broccoli sprouts was stable after simulated gastrointestinal digestion. It inhibited the release of all chemokines selected as inflammatory read-outs, with a more potent effect against MCP-1 (IC50 = 7.81 µM). On the contrary, glucoraphanin (50 µM) was inactive. The molecules were unable to counteract the oxidative damage to DNA (γ-H2AX) and catalase levels; however, the activity of NF-κB and Nrf-2 was modulated by both molecules. The impact on epithelial permeability (TEER) was also evaluated in a Transwell® model. In the context of a pro-inflammatory combination including gliadin, TEER values were recovered by neither sulforaphane nor glucoraphanin. Conversely, in the context of co-culture with activated macrophages (THP-1), sulforaphane inhibited the release of MCP-1 (IC50 = 20.60 µM) and IL-1β (IC50 = 1.50 µM) only, but both molecules restored epithelial integrity at 50 µM. Our work suggests that glucoraphanin should not merely be considered as just an inert precursor at the small intestine level, thus suggesting a potential interest in the framework of CD. Its biological activity might imply, at least in part, molecular mechanisms different from sulforaphane.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsothiocyanatesSulfoxidesGlucosinolatesCeliac DiseaseOximesOxidative StressImidoestersBrassicaHumansCaco-2 CellsGliadinIntestinal MucosaInterleukin-1betaChemokine CCL2CytokinesInterferon-gamma

Stichwörter der Autor:innen

celiac diseaseglucoraphaninglucosinolatesgut barriergut inflammationsulforaphane

Substanzen

glucoraphaninsulforaphaneIsothiocyanatesSulfoxidesGlucosinolatesOximesImidoestersGliadinInterleukin-1betaChemokine CCL2

Autor:innen und Institutionen

  • Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti" (DiSFeB), Università Degli Studi di Milano, 20133 Milan, Italy.
  • Naturalsalus S.r.l., Trezzano Rosa, 20060 Milan, Italy.

ORCID-Profile: Elisa Sonzogni, Giulia Martinelli, Nicole Maranta, Carola Pozzoli, Corinne Bani, Chiara Di Lorenzo, Enrico Sangiovanni, Mario Dell'Agli, Stefano Piazza

Förderung

  • MIUR
  • Naturalsalus s.r.l. (MI) Italy
  • MIUR “Progetto Eccellenza” 2023–2027

Zitieren

APA

Sonzogni, E., Martinelli, G., Fumagalli, M., Maranta, N., Pozzoli, C., Bani, C., Marrari, L. A., Di Lorenzo, C., Sangiovanni, E., Dell'Agli, M., & Piazza, S. (2024). In Vitro Insights into the Dietary Role of Glucoraphanin and Its Metabolite Sulforaphane in Celiac Disease. Nutrients. https://doi.org/10.3390/nu16162743

Vancouver

Sonzogni E, Martinelli G, Fumagalli M, Maranta N, Pozzoli C, Bani C, et al. In Vitro Insights into the Dietary Role of Glucoraphanin and Its Metabolite Sulforaphane in Celiac Disease. Nutrients. 2024. doi:10.3390/nu16162743

BibTeX
@article{Sonzogni2024,
  author = {Sonzogni, Elisa and Martinelli, Giulia and Fumagalli, Marco and Maranta, Nicole and Pozzoli, Carola and Bani, Corinne and Marrari, Luigi Alberto and Di Lorenzo, Chiara and Sangiovanni, Enrico and Dell'Agli, Mario and Piazza, Stefano},
  title = {In Vitro Insights into the Dietary Role of Glucoraphanin and Its Metabolite Sulforaphane in Celiac Disease},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16162743}
}
Kostenlos starten →